Frontiers in Health Sciences
Frontiers in Health Sciences seminar
A warm welcome to Frontiers in Health Sciences seminar on Thursday 28th of September 2023 at 15-16 in Teams.
Topic: The return of the lesion. Lessons from serendipity and perseverance.
Speaker: Juho Joutsa, University of Turku
Juho Joutsa, MD, PhD graduated from University of Turku and completed postdoctoral training at Massachusetts General Hospital and Harvard Medical School. Currently, he is professor of neurology at University of Turku and chief neurologist at Turku University Hospital. He leads Brain Stimulation and Neuroimaging laboratory (www.turkubrainlab.fi) and acts as the chair of Turku Brain and Mind Center.
Prof. Joutsa’s lab’s research work focuses on investigating the neurobiological mechanisms of brain disorders and aims to facilitate development of new treatment options. Joutsa is interested in a wide spectrum of brain disorders but especially neurological movement disorders and addictions. He uses a multimodal approach, combining brain lesions, state-of-the-art brain imaging methods (MRI, PET, SPECT) and brain stimulation techniques (TMS, DBS).
***
Frontiers in Health Sciences seminar
A warm welcome to Frontiers in Health Sciences seminar on Thursday 7th of September 2023 at 10:00-11:00 in Teams.
Topic: Making sense of antisense transcription in the failing heart – mechanistic insights and therapeutic opportunities
Speaker: Olof Gidlöf, Lund University
Heart failure represents the end-stage of all heart disease and is a leading cause of mortality and hospitalization in developed countries. Therapies aimed at improving cardiac mechanical function and neurohormonal control in heart failure remains an unmet clinical need. Natural antisense transcripts (NATs), i.e., non-coding RNAs transcribed from the opposite strand of a protein-coding gene are a common feature throughout the human genome. Their roles as cis-acting transcriptional and post-transcriptional regulators means that NATs could constitute specific and effective targets for RNA-based therapies. In this seminar, recent data from the Gidlöf lab revealing new insights into the biology and therapeutic potential of cardiac NATs will be disseminated.
Olof Gidlöf is associate professor in experimental cardiology and principal investigator of the Cardiovascular Epigenetics unit at Lund University. OG has a background studying the role of non-coding RNA and epigenetics in cardiovascular disease at Lund University, University of Miami and the Scripps Research Institute. Currently, OG’s research is mainly focused on molecular and translational studies of heart failure, with the aim of identifying targets for RNA-based therapies.
To be announced.
Frontiers in Health Sciences seminar
A warm welcome to Frontiers in Health Sciences seminar on Monday 4th of December 2023 at 15:00-16:15 in SN200, Snellmania (Kuopio Campus) and in Teams.
Topic: Eliminating the seeds of relapse – targeting residual disease following targeted therapy
Speaker: Kari Kurppa, University of Turku
The laboratory of Dr. Kurppa aims to understand the means cancer cells use to develop resistance to cancer therapies. The laboratoy’s special focus are the mechanisms that enable the establishment of residual disease, or govern the maintenance of residual tumors following targeted cancer therapy. The overarching goal of Dr. Kurppa’s research is to develop rational combination strategies that will extend the long-term efficacy of clinically used cancer therapies.
https://sites.utu.fi/kurppalab/
This seminar is organized in collaboration with UEF CANCER Research community
To be announced.
Frontiers in Health Sciences seminar
A warm welcome to Frontiers in Health Sciences seminar on Thursday 8th of February 2024 at 15:00-16:00 in CA102, Canthia and in Teams.
Topic: Use of real word data for decision making on medicines
Speaker: Prof. Olaf Klungel, Utrecht University
Olaf Klungel is professor of pharmacoepidemiologic methods at Utrecht University, Utrecht, the Netherlands. He is chair of the division of Pharmacoepidemiology & Clinical Pharmacology and scientific director of the Utrecht Institute for Pharmaceutical Sciences. He is also adjunct professor of Pharmacoepidemiology at the University of Southern Denmark in Odense. He was trained as a pharmacist and epidemiologist. His main research area is the development, improvement and evaluation of innovative methods of observational drug research. Main applications are in the post-registration phase of drug development.Prof. Klungel teaches pharmacoepidemiology and pharmacotherapy to medical and pharmacy students. He is (co-)author of over 350 papers in peer reviewed journals, book chapters and research reports.
To be announced.
Frontiers is Health Sciences_07052024_Reinier Boon
Frontiers in Health Sciences seminar
A warm welcome to Frontiers in Health Sciences seminar on Tuesday 7th of May 2024 at 12:30-13:30 in TTA, Tietoteknia.
Topic: How endothelial cells and non-coding RNAs regulate cardiac aging
Speaker: Professor Reinier Boon
Since 2019 Reinier Boon is a professor at the Amsterdam UMC and at the Goethe University in Frankfurt. Reinier received his PhD degree with honors in 2008 from the Academic Medical Center of the University of Amsterdam. After his post-doc project in the Institute for Cardiovascular Regeneration in Frankfurt, Germany, Dr. Boon continued there as a junior group leader. He received multiple awards for his work on the role of small and long non-coding RNAs in aging of the cardiovascular system, for instance the Outstanding Achievement Award of the European Society of Cardiology in 2019. Dr. Boon’s research is mainly funded by the German Center for Cardiovascular Research (DZHK), the European Research Council (Consolidator grant), the Dutch Heart Foundation (DHF) and the European Union (Horizon 2020). Current research is focused on non-coding RNA and aging of the cardiovascular system, in particular in the context of heart failure.
The seminar is organized by the UEF Faculty of Health Sciences, and the event is open to everyone interested.
Welcome!